Skip to content
‹ Back to IndustriesHealthcare

A Powerful New Direction in Hospital Strategic Planning

Like any business, hospitals need strategic plans to chart their future. Rarely do they go smoothly, but with flexibility and agility, organizations can carefully navigate them. Jerry Darby, VP, Strategic Advisory Services at Covalus, shared his experiences and predictions for the space on Plan. Build. Equip. Darby has 30 years of healthcare planning consulting experience….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
A Powerful New Direction in Hospital Strategic Planning

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Like any business, hospitals need strategic plans to chart their future. Rarely do they go smoothly, but with flexibility and agility, organizations can carefully navigate them. Jerry Darby, VP, Strategic Advisory Services at Covalus, shared his experiences and predictions for the space on Plan. Build. Equip.

Darby has 30 years of healthcare planning consulting experience. He started his career as a pharmacist working in retail and hospital pharmacies. An early challenge of helping a hospital regain its controlled substance license made him realize he wanted to be on the business side of the industry.

“Supporting hospitals in unique situations is interesting. I’ve worked with great people, and, as a consultant, you come into opportunities created by others,” Darby said.

Over the years, Darby has helped prominent hospitals like the Mayo Clinic and Mass General with planning. He explained the plan is just the first step. “You can create the best plan in the world, but with no way to implement it, it’s less likely to be successful.”

The process can be arduous and requires massive changes. “There are hard conversations, but flexibility must be part of the thing, because many things change, and you have to be able to adjust,” Darby added.

The most dramatic change for healthcare has been the pandemic. Darby recalled that some strategic plans had foresight. He mentioned transitioning from double patient rooms to single patient rooms, hospitals being more ICU ready, and other operational pieces.

Now, technology is where investment needs to go, including telehealth, remote monitoring, and ways to evaluate patients from a distance. Darby spoke about the next transition hurdle—being consumer-centric. “Hospitals need to orient around the consumer, and I think the pandemic is changing this and views on healthcare.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512